CD47 and ovarian cancer: It could be demonstrated that by concomitant expression of a CAR targeting the oncofetal antigen TAG-72 (tumor-associated glycoprotein 72), which is frequently expressed in ovarian cancer, together with a CAR engaging CD47, which is overexpressed in ovarian cancer, constitutes an effective dual targeting strategy for ovarian cancer [26].